Amarin Co. plc (NASDAQ:AMRN – Free Report) – Research analysts at Northland Capmk cut their Q2 2023 earnings per share (EPS) estimates for Amarin in a report released on Wednesday, July 19th. Northland Capmk analyst C. Byrnes now expects that the biopharmaceutical company will post earnings of ($0.06) per share for the quarter, down from […]
LCM Capital Management Inc lifted its position in Amarin Co. plc (NASDAQ:AMRN – Free Report) by 17.8% during the 1st quarter, HoldingsChannel reports. The firm owned 331,159 shares of the biopharmaceutical company’s stock after acquiring an additional 50,000 shares during the quarter. LCM Capital Management Inc’s holdings in Amarin were worth $497,000 at the end […]
Amarin (NASDAQ:AMRN – Get Rating) and Sanofi (OTCMKTS:SNYNF – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership. Earnings & Valuation This table compares Amarin and Sanofi’s top-line revenue, earnings […]
Clearbridge Investments LLC lowered its stake in shares of Amarin Co. plc (NASDAQ:AMRN – Get Rating) by 4.2% during the fourth quarter, Holdings Channel reports. The fund owned 535,234 shares of the biopharmaceutical company’s stock after selling 23,480 shares during the period. Clearbridge Investments LLC’s holdings in Amarin were worth $648,000 as of its most […]
Clearbridge Investments LLC cut its position in Amarin Co. plc (NASDAQ:AMRN – Get Rating) by 4.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 535,234 shares of the biopharmaceutical company’s stock after selling 23,480 shares during the period. Clearbridge Investments LLC […]